News
Definitive Healthcare Q1 Review: Revenue Slumps, Structural Issues Surface, And A SELL Rating Sticks
Definitive Healthcare faces structural revenue decline, weak retention, and competitive pressure, raising long-term concerns.
Humana (NYSE:HUM) experienced a 3% price increase last week, which may have been influenced by its recent partnership with Mercy to open new primary care clinics for seniors. This expansion addresses ...
Shares of Humana Inc. HUM rose 1.39% to $234.96 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.38% to 6,045.26 and the ...
An AI analyst made 30 years of stock picks—and outperformed human investors by a 'stunning' degree
Using public information and making small tweaks, an alpha-seeking AI fund manager outperformed 93% of mutual fund managers ...
Copa Holdings boasts a strong balance sheet, industry-leading margins, and resilience through crises. Click here to find out ...
One company, which is a leader in APM, could continue generating high-teens growth, driven by product and go-to-market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results